111In-DTPA-exendin-4

N/A

Report date: 2025/11/21 17:15:40

NME

Base Information

Drug Name111In-DTPA-exendin-4

Drug Alias Name111In-DTPA-exendin-4

ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo)Radiation-emitting products > Nuclides > Indium > 111In +[5]

Mechanisms of ActionGlucagon-like peptide 1 receptor agonists

TargetsGlucagon-like peptide 1 receptor

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesRadboud University Nijmegen

China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Nijmegen

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 2

Inactive IndicationsN/A

Other Information

ATC CodeN/A